| Mrs Gail A Mayer, MS | |
|
309 Collins Ave, Mandan, ND 58554-3002 | |
| (701) 663-9531 | |
| Not Available |
| Full Name | Mrs Gail A Mayer |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 309 Collins Ave, Mandan, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083763775 | NPI | - | NPPES |
| 58554 | Medicaid | ND |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 457 (North Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Gail A Mayer, MS 4204 41st Ave Nw, Mandan, ND 58554-1175 Ph: (701) 663-2277 | Mrs Gail A Mayer, MS 309 Collins Ave, Mandan, ND 58554-3002 Ph: (701) 663-9531 |
News Archive
A multi-disciplinary team of scientists from the National Cancer Centre Singapore, Duke-NUS Graduate Medical School Singapore, and Singapore General Hospital have made a seminal breakthrough in understanding the molecular basis of fibroadenoma, one of the most common breast tumours diagnosed in women.
Researchers at Moffitt Cancer Center have completed a phase II clinical trial to determine the safety and efficacy of dasatinib for patients with higher-risk myelodysplastic syndromes, chronic myelomonocytic leukemia, or acute myeloid leukemia resulting from MDS and have failed treatment with azanucleosides.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that it has received approval from Health Canada, the country's federal department responsible for helping Canadians maintain their health, to market the HeartWare Ventricular Assist System as a bridge to heart transplantation in patients with end-stage heart failure.
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced findings from a post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse-. In this study, Vyvanse demonstrated significant improvement in Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms as measured by the ADHD Rating Scale IV (ADHD-RS IV) and Connors' Parent Rating Scale-Revised Short (CPRS-RS) in children with ADHD aged 6 to 12 years.
Just 13 days in space may be enough to cause profound changes in eye structure and gene expression, report researchers from Houston Methodist, NASA Johnson Space Center, and two other institutions in the October 2013 issue of Gravitational and Space Research.
› Verified 2 days ago
Desiree Crockford, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 901 Division St Nw, Mandan, ND 58554 Phone: 701-751-6500 | |
Mrs. Marti Jo Schuetzle, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2007 8th Ave Se, Mandan, ND 58554 Phone: 701-663-0922 | |
Teresa Rivera, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 901 Division St Nw, Mandan, ND 58554 Phone: 701-751-6500 | |
Lisa Watson, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 405 8th Ave Sw, Mandan, ND 58554 Phone: 701-663-7514 | |
Kelli Marie Stumpf, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1702 E Main St Ste 103, Mandan, ND 58554 Phone: 701-415-0000 Fax: 833-969-0195 | |
Ms. Kathryn L Miller, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 309 Collins Ave, Mandan, ND 58554 Phone: 701-663-9531 |